Sage Therapeutics announced the addition of Elizabeth (Liz) Barrett and George Golumbeski, Ph.D., to the company’s board of directors. Liz Barrett is the president and chief executive officer of UroGen. She previously served as chief executive officer of Novartis Oncology. In that role, she oversaw more than 10,000 associates in 85 countries and was a member of the Novartis executive committee. Prior to Novartis, she was global president, oncology at Pfizer Inc., where she held a series of leadership positions, including president, Europe, global innovative pharma, president, North America, and president, U.S. oncology business unit. George Golumbeski is the president of GRAIL. Dr. Golumbeski previously served as executive vice president of Celgene, leading corporate development. During his nine years at Celgene, he fostered new models for inter-company collaboration.